Role of amicar in surgery for neuromuscular scoliosis

George H. Thompson, Ivan Florentino, Connie Poe-Kochert, Douglas G. Armstrong, Jochen Son-Hing

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

STUDY DESIGN.: A retrospective case-control study. OBJECTIVE.: Evaluate the effectiveness of Amicar in decreasing perioperative blood loss in patients with neuromuscular scoliosis undergoing posterior spinal fusion (PSF) and segmental spinal instrumentation (SSI). SUMMARY OF BACKGROUND DATA.: Previously, a preliminary prospective; prospective randomized double-blind; same-day anterior and posterior spinal fusion; and fibrinogen studies have demonstrated Amicar to be effective in decreasing total perioperative blood loss and transfusion requirements in surgery for idiopathic scoliosis. Increased fibrinogen secretion is a possible explanation. We are now analyzing its effectiveness in neuromuscular scoliosis. METHODS.: Amicar was administered at 100 mg/kg over 15 minute not to exceed 5 g after anesthesia induction. Maintenance is 10 mg/kg/h until wound closure. There were 2 study groups: group 1 (n = 34), no Amicar and group 2 (n = 62) who received Amicar. The majority of patients in both groups had cerebral palsy. Total perioperative blood loss was determined from the estimated intraoperative blood loss and measured postoperative suction drainage. Total perioperative blood loss and transfusion requirements (cell saver and allogeneic) were compared using χ or Fisher exact test. RESULTS.: There was statistically less estimated intraoperative blood loss, total perioperative blood loss, and transfusion requirements in group 2. Postoperative suction drainage was also less but did not reach statistical significance. In group 1, estimated intraoperative blood loss, measured postoperative suction drainage, and total perioperative blood loss were 2194 ± 1626 mL, 903 ± 547 mL, and 3055 ± 1852 mL, whereas in group 2, it was 1125 ± 715 mL, 695 ± 489 mL, and 1805 ± 940 mL. Transfusion requirements were 1548 ± 962 mL in group 1 but only 660 ± 589 mL in group 2 (P < 0.0001). Amicar was equally effective in all diagnoses. There were no complications related to the use of Amicar. CONCLUSION.: Amicar was highly effective in decreasing perioperative blood loss and transfusion requirements in patients with neuromuscular scoliosis undergoing PSF and SSI. It was most effective in decreasing estimated intraoperative blood loss. This results in decreased transfusion requirements, costs, and potential transfusion-related complications.

Original languageEnglish (US)
Pages (from-to)2626-2629
Number of pages4
JournalSpine
Volume33
Issue number24
DOIs
StatePublished - Nov 15 2008

Fingerprint

Aminocaproic Acid
Scoliosis
Blood Transfusion
Spinal Fusion
Suction
Postoperative Hemorrhage
Fibrinogen
Cerebral Palsy
Case-Control Studies
Anesthesia
Maintenance
Costs and Cost Analysis
Wounds and Injuries

Keywords

  • Amicar (epsilon aminocaproic acid)
  • Cerebral palsy
  • Estimated intraoperative blood loss
  • Neuromuscular scoliosis
  • Posteriorspinal fusion
  • Postoperative suction drainage
  • Segmental spinal instrumentation
  • Total perioperative blood loss

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Clinical Neurology

Cite this

Thompson, G. H., Florentino, I., Poe-Kochert, C., Armstrong, D. G., & Son-Hing, J. (2008). Role of amicar in surgery for neuromuscular scoliosis. Spine, 33(24), 2626-2629. https://doi.org/10.1097/BRS.0b013e318187c046

Role of amicar in surgery for neuromuscular scoliosis. / Thompson, George H.; Florentino, Ivan; Poe-Kochert, Connie; Armstrong, Douglas G.; Son-Hing, Jochen.

In: Spine, Vol. 33, No. 24, 15.11.2008, p. 2626-2629.

Research output: Contribution to journalArticle

Thompson, GH, Florentino, I, Poe-Kochert, C, Armstrong, DG & Son-Hing, J 2008, 'Role of amicar in surgery for neuromuscular scoliosis', Spine, vol. 33, no. 24, pp. 2626-2629. https://doi.org/10.1097/BRS.0b013e318187c046
Thompson GH, Florentino I, Poe-Kochert C, Armstrong DG, Son-Hing J. Role of amicar in surgery for neuromuscular scoliosis. Spine. 2008 Nov 15;33(24):2626-2629. https://doi.org/10.1097/BRS.0b013e318187c046
Thompson, George H. ; Florentino, Ivan ; Poe-Kochert, Connie ; Armstrong, Douglas G. ; Son-Hing, Jochen. / Role of amicar in surgery for neuromuscular scoliosis. In: Spine. 2008 ; Vol. 33, No. 24. pp. 2626-2629.
@article{67e696e05ead475f92a2c1945d12507e,
title = "Role of amicar in surgery for neuromuscular scoliosis",
abstract = "STUDY DESIGN.: A retrospective case-control study. OBJECTIVE.: Evaluate the effectiveness of Amicar in decreasing perioperative blood loss in patients with neuromuscular scoliosis undergoing posterior spinal fusion (PSF) and segmental spinal instrumentation (SSI). SUMMARY OF BACKGROUND DATA.: Previously, a preliminary prospective; prospective randomized double-blind; same-day anterior and posterior spinal fusion; and fibrinogen studies have demonstrated Amicar to be effective in decreasing total perioperative blood loss and transfusion requirements in surgery for idiopathic scoliosis. Increased fibrinogen secretion is a possible explanation. We are now analyzing its effectiveness in neuromuscular scoliosis. METHODS.: Amicar was administered at 100 mg/kg over 15 minute not to exceed 5 g after anesthesia induction. Maintenance is 10 mg/kg/h until wound closure. There were 2 study groups: group 1 (n = 34), no Amicar and group 2 (n = 62) who received Amicar. The majority of patients in both groups had cerebral palsy. Total perioperative blood loss was determined from the estimated intraoperative blood loss and measured postoperative suction drainage. Total perioperative blood loss and transfusion requirements (cell saver and allogeneic) were compared using χ or Fisher exact test. RESULTS.: There was statistically less estimated intraoperative blood loss, total perioperative blood loss, and transfusion requirements in group 2. Postoperative suction drainage was also less but did not reach statistical significance. In group 1, estimated intraoperative blood loss, measured postoperative suction drainage, and total perioperative blood loss were 2194 ± 1626 mL, 903 ± 547 mL, and 3055 ± 1852 mL, whereas in group 2, it was 1125 ± 715 mL, 695 ± 489 mL, and 1805 ± 940 mL. Transfusion requirements were 1548 ± 962 mL in group 1 but only 660 ± 589 mL in group 2 (P < 0.0001). Amicar was equally effective in all diagnoses. There were no complications related to the use of Amicar. CONCLUSION.: Amicar was highly effective in decreasing perioperative blood loss and transfusion requirements in patients with neuromuscular scoliosis undergoing PSF and SSI. It was most effective in decreasing estimated intraoperative blood loss. This results in decreased transfusion requirements, costs, and potential transfusion-related complications.",
keywords = "Amicar (epsilon aminocaproic acid), Cerebral palsy, Estimated intraoperative blood loss, Neuromuscular scoliosis, Posteriorspinal fusion, Postoperative suction drainage, Segmental spinal instrumentation, Total perioperative blood loss",
author = "Thompson, {George H.} and Ivan Florentino and Connie Poe-Kochert and Armstrong, {Douglas G.} and Jochen Son-Hing",
year = "2008",
month = "11",
day = "15",
doi = "10.1097/BRS.0b013e318187c046",
language = "English (US)",
volume = "33",
pages = "2626--2629",
journal = "Spine",
issn = "0362-2436",
publisher = "Lippincott Williams and Wilkins",
number = "24",

}

TY - JOUR

T1 - Role of amicar in surgery for neuromuscular scoliosis

AU - Thompson, George H.

AU - Florentino, Ivan

AU - Poe-Kochert, Connie

AU - Armstrong, Douglas G.

AU - Son-Hing, Jochen

PY - 2008/11/15

Y1 - 2008/11/15

N2 - STUDY DESIGN.: A retrospective case-control study. OBJECTIVE.: Evaluate the effectiveness of Amicar in decreasing perioperative blood loss in patients with neuromuscular scoliosis undergoing posterior spinal fusion (PSF) and segmental spinal instrumentation (SSI). SUMMARY OF BACKGROUND DATA.: Previously, a preliminary prospective; prospective randomized double-blind; same-day anterior and posterior spinal fusion; and fibrinogen studies have demonstrated Amicar to be effective in decreasing total perioperative blood loss and transfusion requirements in surgery for idiopathic scoliosis. Increased fibrinogen secretion is a possible explanation. We are now analyzing its effectiveness in neuromuscular scoliosis. METHODS.: Amicar was administered at 100 mg/kg over 15 minute not to exceed 5 g after anesthesia induction. Maintenance is 10 mg/kg/h until wound closure. There were 2 study groups: group 1 (n = 34), no Amicar and group 2 (n = 62) who received Amicar. The majority of patients in both groups had cerebral palsy. Total perioperative blood loss was determined from the estimated intraoperative blood loss and measured postoperative suction drainage. Total perioperative blood loss and transfusion requirements (cell saver and allogeneic) were compared using χ or Fisher exact test. RESULTS.: There was statistically less estimated intraoperative blood loss, total perioperative blood loss, and transfusion requirements in group 2. Postoperative suction drainage was also less but did not reach statistical significance. In group 1, estimated intraoperative blood loss, measured postoperative suction drainage, and total perioperative blood loss were 2194 ± 1626 mL, 903 ± 547 mL, and 3055 ± 1852 mL, whereas in group 2, it was 1125 ± 715 mL, 695 ± 489 mL, and 1805 ± 940 mL. Transfusion requirements were 1548 ± 962 mL in group 1 but only 660 ± 589 mL in group 2 (P < 0.0001). Amicar was equally effective in all diagnoses. There were no complications related to the use of Amicar. CONCLUSION.: Amicar was highly effective in decreasing perioperative blood loss and transfusion requirements in patients with neuromuscular scoliosis undergoing PSF and SSI. It was most effective in decreasing estimated intraoperative blood loss. This results in decreased transfusion requirements, costs, and potential transfusion-related complications.

AB - STUDY DESIGN.: A retrospective case-control study. OBJECTIVE.: Evaluate the effectiveness of Amicar in decreasing perioperative blood loss in patients with neuromuscular scoliosis undergoing posterior spinal fusion (PSF) and segmental spinal instrumentation (SSI). SUMMARY OF BACKGROUND DATA.: Previously, a preliminary prospective; prospective randomized double-blind; same-day anterior and posterior spinal fusion; and fibrinogen studies have demonstrated Amicar to be effective in decreasing total perioperative blood loss and transfusion requirements in surgery for idiopathic scoliosis. Increased fibrinogen secretion is a possible explanation. We are now analyzing its effectiveness in neuromuscular scoliosis. METHODS.: Amicar was administered at 100 mg/kg over 15 minute not to exceed 5 g after anesthesia induction. Maintenance is 10 mg/kg/h until wound closure. There were 2 study groups: group 1 (n = 34), no Amicar and group 2 (n = 62) who received Amicar. The majority of patients in both groups had cerebral palsy. Total perioperative blood loss was determined from the estimated intraoperative blood loss and measured postoperative suction drainage. Total perioperative blood loss and transfusion requirements (cell saver and allogeneic) were compared using χ or Fisher exact test. RESULTS.: There was statistically less estimated intraoperative blood loss, total perioperative blood loss, and transfusion requirements in group 2. Postoperative suction drainage was also less but did not reach statistical significance. In group 1, estimated intraoperative blood loss, measured postoperative suction drainage, and total perioperative blood loss were 2194 ± 1626 mL, 903 ± 547 mL, and 3055 ± 1852 mL, whereas in group 2, it was 1125 ± 715 mL, 695 ± 489 mL, and 1805 ± 940 mL. Transfusion requirements were 1548 ± 962 mL in group 1 but only 660 ± 589 mL in group 2 (P < 0.0001). Amicar was equally effective in all diagnoses. There were no complications related to the use of Amicar. CONCLUSION.: Amicar was highly effective in decreasing perioperative blood loss and transfusion requirements in patients with neuromuscular scoliosis undergoing PSF and SSI. It was most effective in decreasing estimated intraoperative blood loss. This results in decreased transfusion requirements, costs, and potential transfusion-related complications.

KW - Amicar (epsilon aminocaproic acid)

KW - Cerebral palsy

KW - Estimated intraoperative blood loss

KW - Neuromuscular scoliosis

KW - Posteriorspinal fusion

KW - Postoperative suction drainage

KW - Segmental spinal instrumentation

KW - Total perioperative blood loss

UR - http://www.scopus.com/inward/record.url?scp=58949087235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58949087235&partnerID=8YFLogxK

U2 - 10.1097/BRS.0b013e318187c046

DO - 10.1097/BRS.0b013e318187c046

M3 - Article

VL - 33

SP - 2626

EP - 2629

JO - Spine

JF - Spine

SN - 0362-2436

IS - 24

ER -